Josep M.
Alegret Colomé
Publicaciones en las que colabora con Josep M. Alegret Colomé (9)
2018
-
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
American Journal of Cardiology, Vol. 122, Núm. 4, pp. 578-583
2010
-
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey
Chest, Vol. 138, Núm. 5, pp. 1093-1100
-
Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis
Journal of the American College of Cardiology, Vol. 55, Núm. 8, pp. 725-731
-
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation
Chest, Vol. 137, Núm. 2, pp. 263-272
2008
-
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on Atrial Fibrillation
European Heart Journal, Vol. 29, Núm. 9, pp. 1181-1189
2007
-
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation
Journal of the American College of Cardiology, Vol. 49, Núm. 5, pp. 572-577
2006
-
Antithrombotic treatment in real-life atrial fibrillation patients: A report from the Euro Heart Survey on Atrial Fibrillation
European Heart Journal, Vol. 27, Núm. 24, pp. 3018-3026
-
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: A report from the Euro Heart Survey on diabetes and the heart
European Heart Journal, Vol. 27, Núm. 24, pp. 2969-2974
2005
-
Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation
European Heart Journal, Vol. 26, Núm. 22, pp. 2422-2434